MetaVia Inc. (MTVA)

NASDAQ

$1.18

$+0.03

(+2.61%)

Regular Market

MetaVia Inc. (MTVA) Live Price Chart

Last updated: ⁦2026-10-28 19:18:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

MetaVia Inc. (MTVA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.18, with a market capitalization of $8.00M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.97 to $14.85. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$8.00M
Open	$1.17
Day's High	$30.25
Day's Low	$0.97
Previous Close	$1.15
Volume	86.22K
Average Volume	78.23K
P/E Ratio	--
52-Week High	$14.85
52-Week Low	$0.97
Dividend Yield	--
Earnings Date	--

MetaVia Inc. (MTVA) Stock Price Today

MetaVia Inc. (MTVA) is currently trading at $1.18 as of 2026-10-28 19:02:00, up 2.17% ($0.03) from the previous close of $1.15

During today's regular trading session, MTVA has traded between $0.97 and $30.25, with a trading volume of 86.22K shares. The current price is near the lower end of today's range.

MetaVia Inc. (MTVA) 7-Day Stock Price Change

Over the past seven days, MetaVia Inc. (MTVA) moved from $1.23 to $1.18, representing a decline of 4.47% ($0.05).

The stock traded between $1.12 and $1.50 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 65.76 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

MTVA 52-Week Price Position

Position in Range: 1.5%

52W Low$0.97

52W High$14.85

MTVA is currently trading at $1.18, placing it 1.5% of the way from its 52-week low of $0.97 to its 52-week high of $14.85. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is MetaVia Inc. (MTVA)?

MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. Vanoglipel (DA-1241) is a novel GPR119 (GPR119) agonist with development optionality as a standalone or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). Agonism of GPR119 in the gut promotes the release of key gut peptides, glucagon-like peptide-1 (GLP-1), glucagon-dependent insulinotropic polypeptide receptor (GIP), and peptide YY.

MetaVia Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	8
Exchange	NASDAQ
Company Website	https://www.metaviatx.com

How to Buy MetaVia Inc. (MTVA) Stock on MEXC

Eligible investors can buy real shares of MetaVia Inc. (MTVA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for MTVA and Place Your Order

Open the RealStocks trading page and search for MTVA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is MetaVia Inc. (MTVA) stock price today?

MetaVia Inc. (MTVA) is currently trading at $ 1.18, up 2.17% ($0.03) from the previous close of $ 1.15. Intraday prices update in real time during regular trading hours.

2.Is MTVA stock going up or down today?

As of 2026-10-28 19:02:00, MTVA is trading at $ 1.18, up 2.17% ($0.03) from its previous close of $ 1.15. The stock has traded between $ 0.97 and $ 30.25 during today’s regular session. Past price movements do not guarantee future results.

3.What is MTVA pre-market price?

As of 2026-10-28 19:02:00, MTVA is trading at $ 1.17 in pre-market trading, up 1.30% ($0.02) from the previous close of $ 1.15. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is MTVA after-hours price?

As of 2026-10-28 19:02:00, MTVA is trading at $ 1.18 in after-hours trading, up 2.70% ($0.03) from the regular-session close of $ 1.15. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is MTVA stock trading now?

MTVA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does MTVA sit relative to its 52-week high and low?

Over the past 52 weeks, MTVA has traded between a low of $ 0.97 and a high of $ 14.85. At $ 1.18, the stock is positioned 1.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is MetaVia Inc. in?

MetaVia Inc. (MTVA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is MetaVia Inc.'s market capitalization and where is it listed?

MetaVia Inc. is listed on the NASDAQ exchange with a market capitalization of $ 8.00M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is MTVA valued in terms of P/E ratio and EPS?

MTVA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.19. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does MetaVia Inc. pay a dividend?

MetaVia Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.